PEPGEN INC (PEPG)

US7133171055 - Common Stock

7.28  -0.35 (-4.59%)

After market: 7.28 0 (0%)

News Image
4 days ago - Market News Video

RSI Alert: PepGen (PEPG) Now Oversold

News Image
2 months ago - Market News Video

Oversold Conditions For PepGen (PEPG)

News Image
3 months ago - InvestorPlace

PEPG Stock Earnings: PepGen Misses EPS for Q2 2024

PEPG stock results show that PepGen missed analyst estimates for earnings per share the second quarter of 2024.

News Image
3 months ago - BusinessInsider

PEPG Stock Earnings: PepGen Misses EPS for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PepGen (NASDAQ:PEPG) just reported results for the second quarter of 2024.PepGe...

News Image
6 months ago - BusinessInsider

PEPG Stock Earnings: PepGen Beats EPS for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PepGen (NASDAQ:PEPG) just reported results for the first quarter of 2024.PepGen...

News Image
6 months ago - InvestorPlace

PEPG Stock Earnings: PepGen Beats EPS for Q1 2024

PEPG stock results show that PepGen beat analyst estimates for earnings per share the first quarter of 2024.

News Image
6 months ago - PepGen Inc.

PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

– CONNECT1-EDO51 trial preliminary data from 5mg/kg dose cohort expected mid-2024 – – FREEDOM1-DM1 trial preliminary data from at least 5mg/kg dose...

News Image
8 months ago - PepGen Inc.

PepGen to Participate in Upcoming Investor Conferences

BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of...

News Image
8 months ago - PepGen Inc.

PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy

BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of...

News Image
8 months ago - InvestorPlace

PEPG Stock Earnings: PepGen Beats EPS for Q4 2023

PEPG stock results show that PepGen beat analyst estimates for earnings per share the fourth quarter of 2023.

News Image
8 months ago - BusinessInsider

PEPG Stock Earnings: PepGen Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PepGen (NASDAQ:PEPG) just reported results for the fourth quarter of 2023.PepGe...

News Image
8 months ago - PepGen Inc.

PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments

- Enrollment completed for PGN-EDO51 5 mg/kg cohort in CONNECT1-EDO51 Phase 2 clinical trial in DMD patients. The Company expects to announce preliminary...

News Image
9 months ago - Seeking Alpha

PepGen announces pricing of $80.1M underwritten offering (NASDAQ:PEPG)

PepGen Inc. (PEPG) has priced its underwritten offering, expecting to raise approximately $80.1 million through the sale of its common stock.

News Image
9 months ago - PepGen Inc.

PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock

BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of...